MedPath
HSA Approval

TRUQAP FILM-COATED TABLETS 200MG

SIN17111P

TRUQAP FILM-COATED TABLETS 200MG

TRUQAP FILM-COATED TABLETS 200MG

October 14, 2024

ASTRAZENECA SINGAPORE PTE LTD

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantASTRAZENECA SINGAPORE PTE LTD

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

TABLET, FILM COATED

ORAL

Medical Information

L01EX27

Manufacturer Information

ASTRAZENECA SINGAPORE PTE LTD

AstraZeneca AB

Active Ingredients

Capivasertib

200mg

Capivasertib

Documents

Package Inserts

Truqap Approved PI.pdf

Approved: October 14, 2024

Download

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

TRUQAP FILM-COATED TABLETS 200MG - HSA Approval | MedPath